Market closedNon-fractional
Bruker/BRKR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Bruker
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.
Ticker
BRKR
Sector
Healthcare
Trading on
NASDAQ
Industry
Life Sciences Tools and Services
Headquarters
Billerica, United States
Employees
9,707
Website
www.bruker.com
Bruker Metrics
BasicAdvanced
$9.7B
Market cap
23.50
P/E ratio
$2.73
EPS
1.25
Beta
$0.20
Dividend rate
0.31%
Dividend yield
Price and volume
Market cap
$9.7B
Beta
1.25
Dividend rate
$0.20
Financial strength
Current ratio
1.81
Quick ratio
0.836
Long term debt to equity
100.689
Total debt to equity
102.151
Dividend payout ratio (TTM)
7.30%
Interest coverage (TTM)
25.43%
Management effectiveness
Return on assets (TTM)
6.54%
Return on equity (TTM)
30.29%
Valuation
Price to earnings (TTM)
23.498
Price to revenue (TTM)
3.125
Price to book
6.61
Price to tangible book (TTM)
43.68
Price to free cash flow (TTM)
51.781
Dividend yield (TTM)
0.31%
Growth
Revenue change (TTM)
14.49%
Earnings per share change (TTM)
30.06%
3-year revenue growth (CAGR)
12.31%
3-year earnings per share growth (CAGR)
27.43%
3-year dividend per share growth (CAGR)
7.72%
What the Analysts think about Bruker
Analyst Ratings
Majority rating from 11 analysts.
Bruker Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$722M
-15.54%
Net income
$51M
-75.23%
Profit margin
7.05%
-70.67%
Bruker Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.50
$0.74
$0.80
$0.53
-
Expected
$0.49
$0.63
$0.68
$0.46
$0.53
Surprise
3.05%
17.11%
17.43%
14.30%
-
Bruker News
AllArticlesVideos
Cellens Announces Collaboration with Bruker BioAFM to Advance Mechanobiology Technology for Cancer Detection
Business Wire·1 month ago
Bruker Applied Mass Spectrometry Division Showcases High-Performance Solutions for Research and Analysis in Applied Laboratories
Business Wire·2 months ago
Bruker Launches Transformative neofleX™ MALDI-TOF System for Spatial Biology Mass Spec Imaging (MSI) Applications
Business Wire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Bruker stock?
Bruker (BRKR) has a market cap of $9.7B as of July 27, 2024.
What is the P/E ratio for Bruker stock?
The price to earnings (P/E) ratio for Bruker (BRKR) stock is 23.5 as of July 27, 2024.
Does Bruker stock pay dividends?
Yes, the Bruker (BRKR) stock pays dividends to shareholders. As of July 27, 2024, the dividend rate is $0.2 and the yield is 0.31%. Bruker has a payout ratio of 7.3% on a trailing twelve-month basis.
When is the next Bruker dividend payment date?
The next Bruker (BRKR) dividend payment date is unconfirmed.
What is the beta indicator for Bruker?
Bruker (BRKR) has a beta rating of 1.25. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Bruker stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.